In the BPV1.69 line of transgenic mice, the bovine papillomavirus type 1 genome elicits both benign dermal fibroblastic proliferation (fibromatoses) and malignant fibrosarcomas. Because these lesions arise only with time, nonviral factors appear to be involved. We have karyotyped several primary tumors as well as a series of low-passage cell lines derived both from fibromatoses and from fibrosarcomas. The fibrosarcomas, but not the preneoplastic fibromatoses, show consistent abnormalities of one or both of two chromosomes, chromosome 8 (trisomy or duplication) and chromosome 14 (monosomy or translocation). The chromosomal abnormalities are not a direct consequence of the viral integration, which we have mapped to chromosome 15 by in situ hybridization. These results suggest that transgenic mice can be used to study the role(s) of cytogenetic changes in tumorigenesis and may direct the search for genes involved in tumor progression.
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Papillomaviruses are thought to play important roles in the etiology of a variety of human malignancies, most notably in cervical cancers (1, 2) . Studies of bovine papillomavirus type 1 (BPV-1) have provided much knowledge of the molecular biology of this group of DNA viruses (3) . In its natural host BPV-1 induces benign fibropapillomas of the skin. In the laboratory BPV-1 transforms cultured mouse cells (4) , and the products of two early viral genes, E5 and E6, have transforming properties (5, 6) .
One recent approach to the systematic study of the multistep genesis of cancer has been to introduce oncogenes into the mouse genome with the purpose of reducing the number of steps required for tumor induction. Tumorigenesis in transgenic mice models the natural process in that different oncogenes heritably elicit specific types of tumors, and the tumors occur with a pattern that implies oncogenes are necessary but not sufficient for tumor formation (7) .
To dissect the relative participation of papillomaviruses and cellular factors in oncogenesis, Lacey et al. (8) produced a line of transgenic mice (BPV1.69 mice) using a plasmid containing a partial tandem duplication (1.69 copies) of the BPV-1 genome. At 8 or 9 mo of age, mice in this lineage develop two types of skin lesions, fibromatoses and fibrosarcomas (8, 9) . The fibromatoses are characterized by dramatic, but benign, thickening of the dermis with concomitant atrophy of the epidermis and loss of hair. The fibrosarcomas are protuberant dermal tumors that invade locally but have not been seen to metastasize. Both the fibromatoses and the tumors contain extrachromosomal BPV-1 DNA and express viral RNA (10) . In contrast, unaffected skin of the transgenic mice contains only integrated viral DNA that is not expressed (10) . The state of the viral DNA and its expression thus distinguish normal skin from the fibromatoses and the fibrosarcomas but do not differentiate the two pathologic entities. These observations imply that alterations in cellular genes and/or their expression are involved in the development of malignant fibrosarcomas. This line of mice, therefore, may provide an opportunity to dissect some aspects of tumor progression. To this end we have examined the chromosomes of fibrosarcomas and of cell lines established at different stages in this tumorigenesis to identify any consistent chromosomal abnormalities that might direct the search for critical cellular genes.
MATERIALS AND METHODS
Transgenic Mice. The BPV1.69 line of transgenic mice has been described (8) and was produced using a plasmid (pBPV1.69) with a partial tandem duplication (1.69 copies) of the BPV-1 genome in pBR322. The transgenic line carries z5 copies of the integrated plasmid sequence in a head-to-tail tandem array. The BPV.69RI#1 line of transgenic mice was created with a plasmid (p212-3) containing the 69% transforming segment ofthe BPV-1 genome and a 5.3-kilobase (kb) fragment of the rat preproinsulin-1-encoding gene in pML2 (11) . BPV.69RI#1 mice carry -10 copies of the BPVO.69/ insulin gene complex, which segregate as a single genetic locus. This information is consistent with DNA blotting data that indicates a typical concatenate of injected DNA. The transgene is devoid of plasmid sequences, which were removed by gel purification before microinjection. The pathology, as in the BPV1.69 mice, is one of a latent transgenome subject to infrequent activation and tumorigenesis, thus eliminating plasmid sequences as the major effector of latency. In fact, this lineage evidences a lower incidence of skin lesions than the BPV1.69 lineage, which includes vector sequences in the transgene.
Cell Culture and Chromosome Preparation. Cells were grown in Dulbecco's modified Eagle's medium with penicillin at 100 units/ml, streptomycin at 100 gg/ml, and 1o heatinactivated fetal calf serum or in RPMI 1640 medium with the same additives. Cell lines were established from explants of fibromatoses and fibrosarcomas, as described by SippolaThiele et al. (10) , and the characterizations of all lesions were confirmed by histopathologic analyses. For chromosomal analysis tumors were dissociated with collagenase for several hours and then incubated overnight. Chromosome preparations were made by standard techniques either directly or on the following day after methotrexate synchronization and thymidine release. A minimum of 10 cells was karyotyped for each cell line or tumor. Standard mouse chromosome nomenclature has been used to describe the karyotypes whenever possible; the nomenclature for acquired abnormalities of human chromosomes has been used when no adequate nomenclature exists in the mouse system.
In Situ Hybridization. A plasmid (142.6) containing the entire 7.9-kb sequence of BPV-1 was labeled by nicktranslation with two 3H-labeled nucleotides (dTTP and dATP) to a specific activity of 4 x 107 cpm per ,ug of DNA. The probe (10 ng/ml) was hybridized by the method of Harper and Saunders (12) to chromosomes in metaphase that had previously been stained with quinacrine mustard dihydrochloride and photographed for identification. Slides were coated with emulsion, developed after 3-day exposure at 4°C, and stained with 0.06% Wright's stain for scoring silver grains.
RESULTS
Karyotypic Analysis of Lesions ofBPV1.69 Mice. We wished to ascertain whether cytogenetic abnormalities develop during tumorigenesis in the BPV1.69 mice and, if so, whether the changes are consistent with regard to the stage at which they appear and the chromosomal loci affected. Fibroblastic cells derived from normal skin, benign hyperplastic lesions (fibromatoses), and protuberant lesions of BPV1.69 transgenic mice were karyotyped (Table 1) . Included in the study were four primary tumors, eight tumor cell lines, and seven cell lines derived from fibromatoses, two of which proliferated more aggressively both in vivo and in vitro. The constitutional karyotype of the mice is normal, as determined from studies of skin fibroblasts from newborn mice.
In general, the karyotypes of the tumors and tumor lines are complex. However, the number of abnormalities of chromosomes 8 and 14 is striking ( Fig. 1 Table 1 . Dp, duplication; Df, deficiency; T, translocation; In, inversion.
One tumor (4209) is normal with respect to chromosomes 8 and 14 and is exceptional in other ways. The tumor arose in the mouth, an atypical location for fibrosarcomas in the BPV1.69 mice. The doubling time in vitro of cells derived from this line is significantly longer than that of any other tumor, and the cells appear polygonal rather than spindleshaped like those of the other lines (data not shown).
The abnormalities of chromosomes 8 and 14 are specific to the fibrosarcomas, because neither normal skin nor any ofthe fibromatoses evidenced changes in these chromosomes. Moreover, a lymphoma that arose spontaneously in a BPV1.69 mouse was found to be karyotypically normal (Table 1) ; this lymphoma did not express BPV-1 sequences or carry extrachromosomal BPV-1 DNA (10).
Chromosomal Mapping of the BPV1.69 Transgene. Extrachromosomal BPV-1 distinguishes the dermal pathologic entities from normal skin but does not distinguish fibromatoses from fibrosarcomas. Nevertheless, it was conceivable that the BPV-1 DNA is responsible for the consistent chromosomal rearrangements of the fibrosarcomas by virtue of its physical presence in chromosome 8 or 14. As previously shown by blotting experiments and by its Mendelian inheritance, the transgene is present in about five tandem copies at a single chromosomal site. To determine the site, we hybridized 3H-labeled BPV-1 DNA to the chromosomes of skin fibroblasts from newborn transgenic mice. In an analysis of50 cells, 229 (66%) ofthe total 345 grains were concentrated over chromosome 15; 200 (58%) of the grains clustered over bands B3-D2 with a peak at band C. As expected for a single integration site, no other chromosomal region was labeled above background. These results show that the BPV1.69 transgene is integrated at a single location near band C of chromosome 15 (Fig. 2) .
Therefore animal and again after eleven passages-more passages than any of the other tumor lines underwent. Although some changes were seen (i.e., loss of chromosomes 16 and 19 and part of chromosome 10), chromosomes 8 and 14 remained the same as when first studied. Finally, no changes of chromosome 8 or 14 occurred during culture of normal skin fibroblasts or the fibromatoses. One artifact of tissue culture was noted. All of these cells, including the normal fibroblasts, tend to double their chromosome complement. We do not know whether fibromatosis 3142 and tumor lines 860 and 3137-2 were diploid in vivo and only became tetraploid in culture. However, tumor 3135 was certainly tetraploid in vivo because the cells were examined after only 1 day in culture. Ornitz et al. (14) Plasminogen activators are proteases that play roles in tissue remodeling and metastasis during tumor progression (16) . The tissue type and urokinase plasminogen activator genes map to chromosomes 8 and 14, respectively (17) . However, the urokinase plasminogen activator-encoding-gene is near the centromere of chromosome 14 (17) , distant from the site of the translocations we observed. Further, urokinase plasminogen activator is thought to be more important than tissue type plasminogen activator for tumor invasion, and urokinase plasminogen activator-encoding genes appear to be lost. Another candidate gene, the mouse homolog of the human retinoblastoma (RBI) gene, is on mouse chromosome 14 (18) . The retinoblastoma-associated gene is one of a class of genes called tumor-suppressor genes that encoded proteins postulated to have antioncogenic or antiproliferative effects (19, 20) . In humans retinoblastoma development has been shown to correlate with loss of heterozygosity near the retinoblastoma locus by mechanisms that include submicroscopic change, large chromosomal deletion, and chromosome loss (13, (21) (22) (23) (25) (26) (27) .
This transgenic mouse system shares many features with papillomavirus-associated carcinogenesis. Papillomaviruses induce proliferative lesions which, for some viral types, undergo malignant progression after long latency periods. Such progression is believed to be enhanced by specific environmental cofactors (28) (29) (30) (31) (32) 
